Skip to content

Income Tax at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$218K+87.9%
Jazz Pharmaceuticals logo
Jazz PharmaceuticalsJAZZ
$6.1M+134%
Xenon Pharmaceuticals logo
Xenon PharmaceuticalsXENE
-$2.57M-702%
Harmony Biosciences Holdings, Inc. logo
Harmony Biosciences Holdings, Inc.HRMY
$7.2M-38.0%
Nuvation Bio logo
Nuvation BioNUVB
$0
Septerna, Inc. logo
Septerna, Inc.SEPN
$337K

Other financials

Income statement

See full
Revenue$6.2M-96.1%
Operating income-$53.4M-148%
Net income-$50.0M-144%
EPS (diluted)-$0.79-142%

Balance sheet

See full
Cash & equivalents$155.7M-43.4%
Total debt$3.4M-42.5%
Total equity$394.9M+12.8%
Total assets$443.3M+8.9%

Cash flow

See full
Operating cash flow-$60.6M-146%
CapEx$353.0K+132%
Free cash flow-$60.9M-146%

Valuation

See full
Market cap$1.94B+436%
Enterprise value$1.79B+1,855%
P/S60.4×+58.5×

Profitability

See full
Operating margin-577.5%-597pp
Net margin-529.2%-556pp
FCF margin36.2%+18.4pp

Returns & leverage

See full
Return on equity-45.6%-66.1pp
Debt / equity0.0×
Current ratio+0.6×

Where this comes from

Reported directly by Stoke Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.

The official record: Stoke Therapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Stoke Therapeutics, Inc.'s income tax.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Stoke Therapeutics, Inc.'s income tax?
Stoke Therapeutics, Inc. (STOK) reported income tax of -$0 in Q1 2026.
How has Stoke Therapeutics, Inc.'s income tax changed year-over-year?
Stoke Therapeutics, Inc.'s income tax decreased by 100.0% year-over-year, from $1.28M to -$0.
What does income tax mean?
Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.